Real-time enrollment status for this neuroendocrine tumors clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 11:44 PM UTC
| NCT Number | NCT06784752 |
| Recruiting Status | Recruiting |
| Condition | Neuroendocrine Tumors |
| Phase | PHASE3 |
| Target Enrollment | 240 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | September 11, 2026 (Sep 11, 2026) |
As of October 16, 2026: Clinical trial NCT06784752 is currently recruiting participants. This phase3 study for neuroendocrine tumors is actively seeking new participants at 20 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06784752 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06784752 was last updated Sep 11, 2026 (September 11, 2026). HelloStudys verifies this status automatically.